Literature DB >> 4408548

[Analysis of bromsulphthalein-disappearance curves, relative storage capacity, transport maximum, and 45-minutes dye retention (author's transl)].

H J Spech, H Wernze.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4408548     DOI: 10.1007/BF01468539

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  32 in total

1.  The transfer of bromsulphthalein from the plasma to the bile in man.

Authors:  G BARBER-RILEY; A E GOETZEE; T G RICHARDS; J Y THOMSON
Journal:  Clin Sci       Date:  1961-04       Impact factor: 6.124

2.  [Clinical and experimental investigations of bromsulphalein clearance (BSP)].

Authors:  M PILLER; R SCHMID
Journal:  Gastroenterologia       Date:  1962

3.  [Rising slope of purification of B.S.P. Diagnostic and physiopathological significance].

Authors:  B Chevrel; F Lemonnier; J Caroli
Journal:  Presse Med       Date:  1969-12-06       Impact factor: 1.228

4.  Normal sulfobromophthalein retention in established liver disease.

Authors:  L J Schoenfield; G R Onstad; N P Goldstein
Journal:  Am J Dig Dis       Date:  1970-04

5.  Compartmental analysis of sulfobromophthalein transport in normal patients and patients with hepatic dysfunction.

Authors:  S H Quarfordt; H L Hilderman; D Valle; E Waddell
Journal:  Gastroenterology       Date:  1971-02       Impact factor: 22.682

6.  Binding of sulfobromophthalein sodium (BSP) and other organic anions by isolated hepatic cell plasma membranes in vitro.

Authors:  C E Cornelius; J Ben-Ezzer; I M Arias
Journal:  Proc Soc Exp Biol Med       Date:  1967-02

7.  Demonstration and possible interpretation of the triphase curve illustrating the sulfobromophtalein plasma decay after single intravenous administration of the standard dose in human subjects.

Authors:  M Mikulecky
Journal:  Acta Gastroenterol Belg       Date:  1966-11       Impact factor: 1.316

8.  Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.

Authors:  H O WHEELER; J I MELTZER; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

9.  STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.

Authors:  L J SCHOENFIELD; W T FOULK; H R BUTT
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

10.  THE HEPATIC UPTAKE AND EXCRETION OF SULFOBROMOPHTHALEIN AND BILIRUBIN.

Authors:  C A GORESKY
Journal:  Can Med Assoc J       Date:  1965-04-17       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.